-
1 Comment
EVE Investments Limited is currently in a long term downtrend where the price is trading 48.3% below its 200 day moving average.
From a valuation standpoint, the stock is 88.7% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 6.0.
EVE Investments Limited's total revenue rose by 164.9% to $2M since the same quarter in the previous year.
Its net income has increased by 19.3% to $-1M since the same quarter in the previous year.
Finally, its free cash flow grew by 45.9% to $-379K since the same quarter in the previous year.
Based on the above factors, EVE Investments Limited gets an overall score of 4/5.
Exchange | AU |
---|---|
CurrencyCode | AUD |
Industry | Packaged Foods |
ISIN | AU000000EVE3 |
Sector | Consumer Defensive |
Market Cap | 5M |
---|---|
PE Ratio | None |
Beta | 0.81 |
Target Price | None |
Dividend Yield | None |
EVE Health Group Limited, together with its subsidiaries, engages in the retail and distribution of health and wellness products. The company offers organic raw honey and raw honey probiotic concentrates; and contract manufacturing services. It also sells its products through online store. The company was formerly known as EVE Investments Limited. EVE Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EVE.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025